&Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
&Partners's BCAT Position: Q1 2026 in Review
&Partners increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 3.8% in Q1 2026, buying an estimated $26K and bringing the position to 47,914 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.
&Partners first reported a position in BCAT in Q3 2024 and has held it in 7 quarters since. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- &Partners held 47,914 shares of BlackRock Capital Allocation Term Trust worth $677K as of Q1 2026.
- &Partners bought 1,762 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $26K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1526 holding.
- &Partners first reported a position in BlackRock Capital Allocation Term Trust in Q3 2024 and has held it in 7 quarters since.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.